Periodic Reporting for period 4 - RESPINE (REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy)

Summary
The World Health Organization (WHO) has identified degenerative disc disease (DDD) as one of its twelve priority diseases. Currently, there is no effective therapy for DDD, chronic cases often receive surgery, which may lead to biomechanical problems and accelerated...
More information & hyperlinks